-
Greater EpiPen Access, Price Transparency Should Dampen Concern; Goldman Maintains Mylan's Conviction Buy Status
Thursday, August 25, 2016 - 12:59pm | 361Read More...Mylan NV (NASDAQ: MYL)'s announcement that it will offer patient assistance via a coupon that could effectively slash the price of its EpiPen drug by 50 percent should "quell" investor concern, at least according to Goldman Sachs' Jami Rubin. Rubin commented in a report that...
-
Mylan CEO: The Healthcare System Is Broken
Thursday, August 25, 2016 - 9:25am | 358Read More...Mylan NV (NASDAQ: MYL), the seller of a potentially life-saving medical device called EpiPen, saw its share of controversy this week when officials of the U.S. government called into question the company's pricing policies. In 2008, the EpiPen sold for around $100 but has since risen six...
-
Mylan Cuts EpiPen Costs By Up To 50% Via Coupon
Thursday, August 25, 2016 - 8:07am | 347Read More...Mylan NV (NASDAQ: MYL)'s 400 percent price hike to a potentially life-saving device was called into question by members of the U.S. government this week. Mylan, the maker of EpiPen, an epinephrine auto injector used in emergency cases by individuals suffering a severe allergic reaction,...
-
The Active Traders Guide To Hillary Clinton's Rhetoric
Thursday, August 25, 2016 - 6:52am | 538Read More...Just about a year after Democratic presidential nominee sent biotechnology stocks and exchange traded funds tumbling with rhetoric aimed at high drug prices, one would think that any healthcare company and its executives opting to raise prices on devices, pharmaceuticals and treatments by...
-
A Cheaper Option To The EpiPen
Wednesday, August 24, 2016 - 4:57pm | 350Read More...Mylan NV (NASDAQ: MYL) has been in the spotlight this week after the company substantially increased its EpiPen prices. This led to criticism from presidential candidate Hillary Clinton and the White House Meanwhile, further controversy emerged on the back of disproportionate executive salary...
-
Have You Heard About This Generic EpiPen Maker?
Wednesday, August 24, 2016 - 9:01am | 376Read More...Mylan NV (NASDAQ: MYL) is the latest pharmaceutical company to come under government scrutiny. Mylan is the maker of a device that provides epinephrine in the event of anaphylaxis — also known as the EpiPen. According to Fortune, Mylan built the EpiPen from a "weakening enterprise" in 2007 to...
-
Teva Says Its Generic EpiPen Will Be 'Significantly Delayed'
Tuesday, March 1, 2016 - 2:53pm | 229Read More...Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA) announced in a regulatory filing on Monday that it has received notice from the U.S. Food and Drug Administration (FDA) related to its epinephrine. Teva said that the FDA identified "certain major deficiencies" and now expects its epinephrine...
